EdwardFoxMD
Neurology • Round Rock, TXNeuroimmunology/Multiple Sclerosis, Sleep Medicine
Central Texas Neurology Consultants
Dr. Fox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16040 Park Valley Dr
Ste 100
Round Rock, TX 78681Phone+1 512-218-1222Fax+1 512-218-1393
Education & Training
Baylor College of MedicineResidency, Neurology, 1989 - 1992- Baylor College of MedicineInternship, Internal Medicine, 1988 - 1989
- Baylor College of MedicineClass of 1988
Certifications & Licensure
TX State Medical License 1990 - 2026- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis Start of enrollment: 2007 Nov 01
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 1 citationsSerum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.Amit Bar-Or, Xavier Montalban, Xixi Hu, Harald Kropshofer, Petra Kukkaro
Neurology and Therapy. 2023-02-01 - 2 citationsWorking to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristicsChristopher N. Sciamanna, Noel H. Ballentine, Melissa Bopp, Vernon M. Chinchilli, Joseph T. Ciccolo
Trials. 2021-11-15 - 10 citationsB cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.Amy E. Lovett-Racke, Yuhong Yang, Yue Liu, Matthew Gormley, Emma E. Kraus
Journal of Neuroimmunology. 2021-10-15
Press Mentions
The University of Illinois School of Medicine Rockford Is Considering Adding a New $ 100 Million Building to Its Campus for Rural Health SciencesAugust 13th, 2021
#AAN2019 — Ublituximab Safe, Well-Tolerated in Extension Study of Phase 2 Trial in Relapsing MSMarch 15th, 2019
#ECTRIMS2018 – Ublituximab Markedly Reduces Lesions, Promotes B-cell Depletion, Halts Disability Progression in Phase 2 TrialSeptember 28th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
